We think dividend-paying quality pharmaceutical stocks Pfizer Inc, Merck & Co., Inc, and Bristol-Myers Squibb Company could be solid additions to one’s portfolio now to secure a steady income stream.

One of the biggest events in healthcare annually, the American Society of Hematology’s annual meeting (56th!) begins on December 6, but abstracts from the conference will be released this morning. Here's a primer on the stocks to watch.

Thinking that lending somehow can lead GDP is an illusion. There is more to economic recovery than sound banks.

Merck & Co. reported third quarter 2014 earnings of 90 cents per share, beating the Zacks Consensus Estimate of 88 cents. Earnings, however, declined 2.2% from the year-ago period.

December E-mini S&Ps (ESZ14 -0.22%) this morning are down -0.20% and European stocks are down -0.55%.

AbbVie's Shire deal is dead; stocks perk up on Ebola treatment linkage